NA Proactive news snapshot: Tetra Bio-Pharma, Bragg Gaming Group, Real Luck Group, Cloud DX UPDATE …
A glance at some of the day's highlights from the Proactive Investors US and Canada newswires
Your daily round-up from the world of Proactive
Tetra Bio-Pharma Inc (TSE:TBP) (OTCQB:TBPMF) (FRA:JAM1) said it has shipped its investigational new drug, QIXLEEF, to the US to initiate the planned REBORN1 study of patients with breakthrough cancer pain. REBORN1 will evaluate cannabis as an alternative to morphine sulfate immediate release (MSIR), an opioid, in the management of breakthrough pain. Breakthrough pain refers to sudden intense increases or flare-ups of pain that generally last for a short period. The company has completed the manufacturing of QIXLEEF and received the necessary cannabis export permit from Health Canada. QIXLEEF is a botanical drug product with a fixed ratio of THC and CBD that is inhaled through a vaporizer.